Updated:
Orange Grove Bio LLC
Orange Grove Bio LLC is a life sciences investment firm with offices in the US and China, focused on early-stage therapeutic and biotechnology companies.
Orange Grove Bio LLC
Orange Grove Bio LLC operates as a life sciences- and therapeutics-focused investment firm, with reported office locations that span major US biotech hubs—Pasadena, Boston, Indianapolis, Chicago, Southfield—as well as Shanghai, China. The firm appears to allocate capital across early-stage biotechnology companies and therapeutic platforms, though no founding year, AUM, or named principals are disclosed in public records. The firm targets the biotechnology and life sciences sector, likely with a focus on novel therapeutics, drug development, and platform technologies. Its multi-city footprint suggests an intention to access deal flow from both US academic and research clusters and Asian biotech ecosystems. The firm does not publicly disclose its investment vehicle structures, fund sizes, or portfolio companies. No recent operational events—such as fund closings, leadership changes, or notable investments—have been publicly reported in the last 24 months. The firm maintains a low public profile, and its professional headcount, team composition, and any associated philanthropic or adjacent vehicles are not identifiable from available sources. A key structural differentiator is the firm’s stated bi-coastal and international office network, which is uncommon for a firm of its apparent scale and may be designed to source cross-border life sciences opportunities. Without a confirmed leadership team or public track record, the firm’s actual deal capacity and expertise remain opaque.
General information
Firm type
Venture Capital
Year founded
—
AUM
Undisclosed
Location
Region
North America
Country
United States
City
Pasadena
Corporate office
Pasadena, CA, United States
Additional offices
Boston, MA, United States · Shanghai, China · Indianapolis, IN, United States · Southfield, MI, United States · Chicago, IL, United States
Sector focus
Frequently asked questions
Who leads investment decisions at Orange Grove Bio?
The firm does not publicly name any principals or investment committee members. No management team is listed on its website or in public records, which limits visibility into its decision-making structure.
What types of life sciences companies does Orange Grove Bio invest in?
Based on the firm’s name and sector, it likely targets early-stage biotechnology and therapeutic companies. Its office locations in major biotech hubs (Boston, Pasadena, Indianapolis, Chicago) suggest a focus on novel drug development and platform technologies, but no specific stage or subsector is confirmed.
Is Orange Grove Bio structured as a venture capital fund or a family office?
Publicly available information does not specify the firm’s legal structure. The firm lists itself as a limited liability company and maintains multiple US and international offices, which could be consistent with a venture capital firm, a single-family office, or an investment holding entity.
How large is Orange Grove Bio's investment portfolio?
The firm does not disclose its AUM, fund size, or any portfolio companies in public records. Its investment scale remains unknown.
Where is Orange Grove Bio headquartered?
The firm’s primary office appears to be in Pasadena, California, based on public listings. Additional offices are reported in Boston, Shanghai, Indianapolis, Southfield (Michigan), and Chicago.
Does Orange Grove Bio invest internationally?
The firm has an office in Shanghai, China, suggesting an interest in cross-border life sciences deals between the United States and Asia. However, no international investments have been publicly confirmed.
What is the firm's investment stage focus?
Without public disclosures, the firm’s stage focus is not confirmed. The lack of reported fund sizes or portfolio companies makes it difficult to determine whether it targets seed, early-stage, growth, or later-stage biotech investments.
Profile maintained by Altss using OSINT (open-source intelligence), regulatory filings, licensed data partners, and verified direct submissions. Read the methodology. Last updated: . Continuous refresh with full update cycles at least every 30 days.
Need institutional-grade insight on family offices?
Altss delivers:
Prefer a guided tour?
We’ll walk you through: